Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest update is out from Cogstate Ltd ( (AU:CGS) ).
Cogstate Ltd has announced an update regarding its ongoing on-market buy-back program, with a total of 210,288 ordinary fully paid securities bought back on the previous day, adding to the cumulative total of 5,571,816 securities repurchased. This buy-back initiative is part of the company’s strategy to optimize its capital structure and potentially enhance shareholder value, reflecting a proactive approach in managing its financial resources.
More about Cogstate Ltd
Cogstate Ltd operates in the healthcare industry, specializing in the development and commercialization of cognitive tests and assessments. The company focuses on providing solutions for clinical trials, academic research, and healthcare markets, aiming to enhance the measurement of cognitive function.
Average Trading Volume: 113,628
Technical Sentiment Signal: Buy
Current Market Cap: A$235.5M
See more data about CGS stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers , and find the ideal broker for your trades.
Report an Issue